These findings suggest that KPNA2 functions as a critical mediator in both telomere biology and HCC progression, targeting the KPNA2 nuclear transport pathway may inhibit tumor growth by disrupting the localization of key oncogenic proteins and telomerase components and may serve as a promising therapeutic target for liver cancer. This evidence concerns the gene KPNA2 and hepatocellular carcinoma.